Fabrinet vs Roivant Sciences Ltd. Common Shares — how do they compare? Fabrinet trades at $493 (market cap $17.46B), while Roivant Sciences Ltd. Common Shares trades at $35.12 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is the larger of the two by market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, Fabrinet nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Fabrinet for 30 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| FN | ROIV | |
|---|---|---|
Market Cap | $17.46B | $24.72B |
Volume | 1,199,886 | 6,279,442 |
Sector | Technology | Health |
52-Week High | $746.47 | $41.81 |
52-Week Low | $361.94 | $16.04 |
Typical Hold Time | 30 Days | 0 Days |
Enterprise Value | $16.59B | $20.99B |
Signals from Pluang's Aura AI — not financial advice
Fabrinet (FN) trades at $486.8, down 2.25% on the day, amid a mixed technical picture with a bullish moving average signal but overbought RSI levels. Fundamentally, the company shows strong growth with Q2 2026 EPS of $4.10 beating expectations, revenue projected to rise to $4.6B in 2026, and robust profitability metrics including a 21.33% ROE. Recent news highlights surging AI data center demand driving expansion.
The outlook is positive given analyst consensus of a $769.50 price target and 75% buy ratings, though risks include customer concentration and high capital expenditures impacting cash flow. The stock offers exposure to AI infrastructure growth but requires monitoring of execution and competitive pressures.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Fabrinet provides advanced optical and electromechanical manufacturing services to original equipment manufacturers. It specializes in complex products for telecom, automotive, and medical industries.
Read more on FN →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →